117718-84-0

Basic information

• Product Name: 6-bromoimidazo[1,2-a]pyrazin-8-amine
• Synonyms: 6-bromoimidazo[1,2-a]pyrazin-8-amine;8-Amino-6-bromoimidazo[1,2-a]pyrazine;Imidazo[1,2-a]pyrazin-8-amine,6-bromo-;2-a]pyrazin-8-aMine;8-bromoimidazo[1,2-a]pyrazin-6-amine
• CAS NO: 117718-84-0
• Molecular Formula: C₆H₅BrN₄
• Molecular Weight: 213.03
• Product Categories: CHIRAL CHEMICALS
• Mol File: 117718-84-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Density: 2.098 g/cm³
• Refractive Index: 1.831
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 6-bromoimidazo[1,2-a]pyrazin-8-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-bromoimidazo[1,2-a]pyrazin-8-amine(117718-84-0)
• EPA Substance Registry System: 6-bromoimidazo[1,2-a]pyrazin-8-amine(117718-84-0)

Safety Data

• Hazardous Substances Data: 117718-84-0(Hazardous Substances Data)

Usage

General Description

6-bromoimidazo[1,2-a]pyrazin-8-amine is a chemical compound with the molecular formula C6H5BrN6. It is a heterocyclic compound containing a bromine atom and an imidazole ring fused to a pyrazine ring. 6-bromoimidazo[1,2-a]pyrazin-8-amine is often used as a building block in the synthesis of pharmaceutical drugs and other organic compounds. It has potential applications in medicinal chemistry, particularly in the development of new drugs for the treatment of various diseases. Additionally, it can also be used as a research tool in chemical and biological studies due to its unique structure and properties. Overall, 6-bromoimidazo[1,2-a]pyrazin-8-amine is a versatile and valuable chemical compound with a wide range of potential applications in various fields.

InChI:InChI=1/C6H5BrN4/c7-4-3-11-2-1-9-6(11)5(8)10-4/h1-3H,(H2,8,10)

Upstream product

• 63744-22-9 6,8-dibromoimidazo[1,2-a]pyrazine 

Downstream Products

• 1421425-95-7 C₂₇H₂₅N₉O 
• 117718-88-4 imidazo[1,2-a]pyrazin-8-amine 

Relevant articles and documents

IMIDAZO[1,2-A]PYRAZINE MODULATORS OF THE ADENOSINE A2A RECEPTOR

The present invention relates to the compound of formula (I) and salts, stereoisomers, tautomers, isotopologues,or N-oxides thereof. The present invention is further concerned with the use of such a compound or salt, stereoisomer, tautomer, isotopologues,or N-oxide thereof as medicament and a pharmaceutical composition comprising said compound.

6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF

A composition comprises a compound of Formula (I) the pharmaceutically acceptable salts, hydrates, solvates, crystal forms, diastereomers, prodrugs, or mixtures thereof. The composition is of particular utility in the treatment of kinase-implicated disord